P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA

por Frigault, M., Sher, S., Ravikrishnan, J., Izumi, R., Ware, J., Wong, H., Johnson, A., Stelte-Ludwig, B., Byrd, J., Sampath, D., Rogers, K., Woyach, J., Lapalombella, R., Hamdy, A.
Publicado 2022

P1250: EU-SOX11CCND1: A NOVEL IMMUNOCOMPETENT MURINE MODEL OF MANTLE CELL LYMPHOMA

por Brown, F., Sloan, S., Helmig-Mason, J., Hinterschied, C., Long, M., Chan, W. K., Shindiapina, P., Leshchenko, V., Edwards, D., Vaddi, K., Scherle, P., Lapalombella, R., Alinari, L., Parekh, S., Baiocchi, R. A.
Publicado 2022